Skip to main content
Premium Trial:

Request an Annual Quote

CollabRx Inks Distribution Partnership with Projects In Knowledge

Premium

CollabRx said this week that is has signed a multi-year agreement with Projects In Knowledge, a developer of digital and mobile information tools and continuing medical education programs, to jointly distribute software applications to over 35,000 oncologists and clinicians in its clinician network.

Under the terms of the agreement, the partners will integrate CollabRx's Therapy Finder applications into Projects In Knowledge's @Point of Care360 platform, an interactive medical textbook that gives clinicians access to educational resources.

CollabRx's Therapy Finder is a series of web-based applications for oncology that help clinicians and their patients select the most appropriate treatments for tumors. These apps use data from an underlying proprietary knowledgebase that the company has developed that contains aggregated data from multiple public sources including published papers, conference abstracts, clinical trials, and diagnostic guidelines (BI 2/22/2013).

The partners said that they will seek support from pharmaceutical and biotechnology companies in the form of educational grants to conduct their initial activities and that they will explore other fundraising mechanisms to support later phases of the partnership.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.